39
Participants
Start Date
June 30, 2015
Primary Completion Date
September 19, 2017
Study Completion Date
September 19, 2017
IDH1 peptide vaccine
Charité Berlin, Neurosurgery, Berlin
University Hospital Dresden, Neurosurgery, Dresden
University Hospital Essen, Internal Medicine, Essen
University Hospital Frankfurt, Neurooncology, Frankfurt am Main
University Hospital Freiburg, Neurosurgery, Freiburg im Breisgau
University Hospital Heidelberg, Neurology Clinic, Heidelberg
LMU, University Hospital Munich, Munich
University Hospital Tuebingen, Neurooncology, Tübingen
University Hospital Heidelberg
OTHER
German Cancer Research Center
OTHER
Neuro-Oncology Working Group of the German Cancer Society
NETWORK
National Center for Tumor Diseases, Heidelberg
OTHER